1 Min Read
May 18 (Reuters) - Acura Pharmaceuticals Inc
* Acura Pharmaceutical initiates second clinical study on LTX-04 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.